Skip to main content

Table 2 Six months follow-up data of DR-TB patients treated with IFN gamma

From: Adjuvant interferon gamma in patients with drug – resistant pulmonary tuberculosis: a pilot study

Patient

1

2

3

4

5

6

7

8

Drug regimen

ETB

 

ETB

ETB

 

ETB

  
  

RIF

  

RIF

 

RIF

RIF

 

ETN

 

ETN

ETN

 

ETN

  
  

ETB

  

ETB

 

ETB

ETB

 

PRZ

 

PRZ

PRZ

 

PRZ

  
  

PRZ

  

PRZ

 

PRZ

PRZ

 

CPF

 

CPF

CPF

 

CPF

  
  

KAN

  

KAN

 

KAN

KAN

 

KAN

 

KAN

AMK

 

KAN

  

Gain BMI (Kg/m 2 )

1.8

0.4

0.4

0.4

0.3

2.2

1.8

- 2.1!

Sputum smear status

Negative

Negative

Negative

Negative

Negative

Negative

Negative

Negative

Sputum culture status

Negative

Negative

Negative

Negative

Negative

Negative

Negative

Negative

Conversion time

2 mo.

3 mo.

3 mo.

1 mo.

3 mo.

2 mo.

2 mo.

3 mo.

Thorax X-ray

Residual fibrosis

Reabsorption and residual fibrosis

Residual bilateral fibrosis.

Lesions resolution

Residual fibrosis

Lesions size reduction

Residual fibrosis

Lesions size reduction

GSR (mm/h)

5

48

26

40

42

20

23

77

  1. Legend: see Table 1
  2. ! Lost body weight